As shown in S7 Fig., we observed no significant difference in SLC2A2, SLC2A3, and SLC2A4 expression between the pre-S2 mutant transgenic HCC and nontumorous liver tissues. This evidence concerns the gene SLC2A3 and hepatocellular carcinoma.